Cost-effectiveness analysis of human papillomavirus vaccination in South Africa accounting for human immunodeficiency virus prevalence
GHDx Entry last modified on: Jan 31, 2023
HPV
Dataset Records for HPV
Displaying 51 - 100 of 200
Universal vaccination with the quadrivalent HPV vaccine in Austria: impact on virus circulation, public health and cost-effectiveness analysis
GHDx Entry last modified on: Jan 31, 2023
Clinical effectiveness and cost-effectiveness of quadrivalent human papillomavirus vaccination in HIV-negative men who have sex with men to prevent recurrent high-grade anal intraepithelial neoplasia
GHDx Entry last modified on: May 30, 2020
United States National Health Interview Survey 2011
Survey:
Cross-sectional - Household - Individual - Interview - Nationally representative
United States National Health and Nutrition Examination Survey 2011-2012
Survey:
Cross-sectional - Exam - Household - Individual - Interview - Nationally representative
Norway Surveillance System for Communicable Diseases 2011
Meldingssystem for smittsomme sykdommer (MSIS)
Epi surveillance:
Subnationally representative
The epidemiological and economic impact of a quadrivalent human papillomavirus (hpv) vaccine in Estonia
GHDx Entry last modified on: Jan 31, 2023
United States National Health Interview Survey 2010
Survey:
Cross-sectional - Household - Individual - Interview - Nationally representative
New Zealand Sexually Transmitted Infections Annual Surveillance Report 2014
GHDx Entry last modified on: Nov 6, 2018
Dominican Republic Health Statistical Yearbook 2010
Anuario de Estadísticas de Salud, 2010
Report:
Health facility - Subnationally representative
Model-based impact and cost-effectiveness of cervical cancer prevention in the Extended Middle East and North Africa (EMENA)
GHDx Entry last modified on: Jan 31, 2023
The clinical benefit and cost-effectiveness of human papillomavirus vaccination for adult women in the Netherlands
GHDx Entry last modified on: Jan 31, 2023
Norway Surveillance System for Communicable Diseases 2010
Meldingssystem for smittsomme sykdommer (MSIS)
Epi surveillance:
Subnationally representative
Model-based impact and cost-effectiveness of cervical cancer prevention in sub-Saharan Africa
GHDx Entry last modified on: Jan 31, 2023
Comparative cost-effectiveness of the quadrivalent and bivalent human papillomavirus vaccines: a transmission-dynamic modeling study
GHDx Entry last modified on: Jan 31, 2023
Brazil Information System for Notifiable Diseases 2009
Sistema de Informação de Agravos de Notificação (SINAN) 2009
Epi surveillance:
Subnationally representative
United States National Health and Nutrition Examination Survey 2009-2010
Survey:
Cross-sectional - Exam - Household - Individual - Interview - Nationally representative
Mexico SUIVE Epidemiology Bulletin Week 52 2009
Boletín Epidemiológico Nacional Sistema de Vigilancia Epidemiológica Sistema Único de Información Semana 52, 2009
Epi surveillance:
Subnationally representative
Cost and effectiveness evaluation of prophylactic HPV vaccine in developing countries
GHDx Entry last modified on: Jan 31, 2023
Determinantes de salud sexual e ITS en adolescentes rurales, escolarizados, Medellín, Colombia, 2008
GHDx Entry last modified on: Mar 19, 2021
New Zealand Sexually Transmitted Infections Annual Surveillance Report 2013
GHDx Entry last modified on: Nov 6, 2018
Cost-effectiveness of the prophylactic HPV vaccine: an application to the Netherlands taking non-cervical cancers and cross-protection into account
GHDx Entry last modified on: Jan 31, 2023
Norway Surveillance System for Communicable Diseases 2009
Meldingssystem for smittsomme sykdommer (MSIS)
Epi surveillance:
Subnationally representative
Comparative evaluation of the potential impact of rotavirus versus HPV vaccination in GAVI-eligible countries: a preliminary analysis focused on the relative disease burden
GHDx Entry last modified on: Jan 31, 2023
Brazil Information System for Notifiable Diseases 2008
Sistema de Informação de Agravos de Notificação (SINAN) 2008
Epi surveillance:
Subnationally representative
Prevention of HPV-related cancers in Norway: cost-effectiveness of expanding the HPV vaccination program to include pre-adolescent boys
GHDx Entry last modified on: Jan 31, 2023
United States Behavioral Risk Factor Surveillance System 2008
Survey:
Cross-sectional - Household - Individual - Interview - Subnationally representative
United States National Health Interview Survey 2008
Survey:
Cross-sectional - Household - Individual - Interview - Nationally representative
New Zealand Sexually Transmitted Infections Annual Surveillance Report 2012
GHDx Entry last modified on: Nov 6, 2018
Norway Surveillance System for Communicable Diseases 2008
Meldingssystem for smittsomme sykdommer (MSIS)
Epi surveillance:
Subnationally representative
Vaginal Infections of Albanian women Infected with HPV and their impact in intraepithelial cervical lesions evidenced by Pap test
GHDx Entry last modified on: Mar 22, 2024
A cost-utility analysis of cervical cancer vaccination in preadolescent Canadian females
GHDx Entry last modified on: Jan 31, 2023
Economic modelling assessment of the HPV quadrivalent vaccine in Brazil: a dynamic individual-based approach
GHDx Entry last modified on: Jan 31, 2023
Australia HIV, Viral Hepatitis and Sexually Transmissible Infections Annual Surveillance Report 2017
HIV, Viral Hepatitis and Sexually Transmissible Infections in Australia, Annual Surveillance Report 2017
Report:
Epi surveillance - Subnationally representative
United States National Longitudinal Study of Adolescent to Adult Health 2007-2009, Wave 4
Add Health Wave IV, 2008-2009
Survey:
GPS coordinates (GIS) - Household - Individual - Interview - Longitudinal - Nationally representative
Cost-effectiveness of vaccination with a quadrivalent HPV vaccine in Germany using a dynamic transmission model
GHDx Entry last modified on: Jan 31, 2023
Novel health economic evaluation of a vaccination strategy to prevent HPV-related diseases: the BEST study
GHDx Entry last modified on: Jan 31, 2023
Association of HPV infection and Chlamydia trachomatis seropositivity in cases of cervical neoplasia in Midwest Brazil
GHDx Entry last modified on: Mar 22, 2024
New Zealand Sexually Transmitted Infections Annual Surveillance Report 2011
GHDx Entry last modified on: Nov 6, 2018
Modelling the economic value of cross- and sustained-protection in vaccines against cervical cancer
GHDx Entry last modified on: May 30, 2020
Norway Surveillance System for Communicable Diseases 2007
Meldingssystem for smittsomme sykdommer (MSIS)
Epi surveillance:
Subnationally representative
Economic evaluation of policy options for prevention and control of cervical cancer in Thailand
GHDx Entry last modified on: Jan 31, 2023
Brazil Information System for Notifiable Diseases 2007
Sistema de Informação de Agravos de Notificação (SINAN) 2007
Epi surveillance:
Subnationally representative
Cost-effectiveness evaluation of a quadrivalent human papillomavirus vaccine in Belgium
GHDx Entry last modified on: Jan 31, 2023
Too late to vaccinate? The incremental benefits and cost-effectiveness of a delayed catch-up program using the 4-valent human papillomavirus vaccine in Norway
GHDx Entry last modified on: Jan 31, 2023
Cost effectiveness analysis of including boys in a human papillomavirus vaccination programme in the United States
GHDx Entry last modified on: May 30, 2020
New Zealand Sexually Transmitted Infections Annual Surveillance Report 2010
GHDx Entry last modified on: Nov 6, 2018
Norway Surveillance System for Communicable Diseases 2006
Meldingssystem for smittsomme sykdommer (MSIS)
Epi surveillance:
Subnationally representative
HPV16/18 vaccination to prevent cervical cancer in The Netherlands: model-based cost-effectiveness
GHDx Entry last modified on: Jan 31, 2023
Cost-effectiveness analysis of a cervical cancer vaccine in five Latin American countries
GHDx Entry last modified on: Jan 31, 2023
Subscribe